Normal phase high performance liquid chromatography for determination of paclitaxel incorporated in a lipophilic polymer matrix.
A normal phase (NP) high performance liquid chromatography (HPLC) method was developed for analysis of paclitaxel incorporated in poly(sebacic-co-ricinoleic acid), a lipophilic polymer matrix utilized for preparation of an injectable formulation for the localized delivery of paclitaxel. Thin layer chromatography experiments revealed that separation of paclitaxel from the polymer is dependent on the eluting strength (solvent strength) of the mobile phase. The HPLC system consists of a Purospher STRAR Si analytical HPLC column (5 microm, 250mm x 4mm, Merck), and 1-2.5% (v/v) methanol in dichloromethane as the mobile phase. Detection was by UV absorbance at 240 and 254 nm. The effect of the mobile phase composition on paclitaxel retention, peak shape and column efficiency, and the influence of the sample loading on the shape of the paclitaxel peak were studied. The mobile phases used for the chromatography consisted of 1.5% (v/v) methanol in dichloromethane. Paclitaxel was determined in the formulation and in the samples from degradation studies using UV detection at a wavelength of 254 nm. UV detection at 240 nm has advantages for following polymer matrix degradation products due to higher detector response at this wavelength. The utility of the proposed NP HPLC approach was demonstrated by assessment of intra- and inter-batch content uniformity, and by the determination of paclitaxel content after 7 and 60 days exposure of the paclitaxel-loaded polymer matrix to in vitro and in vivo degradation.
Vaisman
Boris
B
Department of Medicinal Chemistry and Natural Products, Faculty of Medicine, School of Pharmacy, The Hebrew University of Jerusalem, 91120 Jerusalem, Israel.
Shikanov
Ariella
A
Domb
Abraham J
AJ
D000972:Antineoplastic Agents, Phytogenic / Q000032:analysis*; D002138:Calibration; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D002855:Chromatography, Thin Layer; D008055:Lipids / Q000737:chemistry*; D017239:Paclitaxel / Q000032:analysis*; D011108:Polymers / Q000737:chemistry*; D011786:Quality Control; D012015:Reference Standards; D013056:Spectrophotometry, Ultraviolet
D000972:Antineoplastic Agents, Phytogenic; D008055:Lipids; D011108:Polymers; D017239:Paclitaxel